We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
+15.79%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$48.8B
AUM Growth
+$4.38B
(+9.9%)
Cap. Flow
-$540M
Cap. Flow
% of AUM
-1.11%
Top 10 Holdings %
Top 10 Hldgs %
19.02%
Holding
2,611
New
251
Increased
862
Reduced
1,166
Closed
311
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$479M |
| 2 |
Costco
COST
|
+$402M |
| 3 |
Netflix
NFLX
|
+$355M |
| 4 |
Nike
NKE
|
+$321M |
| 5 |
Atlassian
TEAM
|
+$312M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$768M |
| 2 |
Cisco
CSCO
|
+$334M |
| 3 |
Amgen
AMGN
|
+$283M |
| 4 |
Fortinet
FTNT
|
+$267M |
| 5 |
DoorDash
DASH
|
+$251M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.88% |
| 2 | Financials | 15.2% |
| 3 | Healthcare | 13.93% |
| 4 | Consumer Discretionary | 13.71% |
| 5 | Industrials | 8.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
Limoneira
LMNR
$237M
| $194K | ﹤0.01% |
+12,400
| New | +$196K |
|
|
HTT
2127
High Templar Tech Ltd
HTT
$377M
| $194K | ﹤0.01% |
61,684
-36,500
| -37% | -$101K |
|
|
IMA
2128
ImageneBio Inc
IMA
$63.1M
| $193K | ﹤0.01% |
12,008
-609
| -5% | -$8.95K |
|
|
RAPT
2129
DELISTED
RAPT Therapeutics
RAPT
| $189K | ﹤0.01% |
23,673
-17,065
| -42% | -$130K |
|
2130
Angi Inc
ANGI
$224M
| $189K | ﹤0.01% |
12,366
-10,134
| -45% | -$146K |
|
2131
OmniAb
OABI
$294M
| $188K | ﹤0.01% |
+107,930
| New | +$181K |
|
2132
InfuSystem Holdings
INFU
$184M
| $187K | ﹤0.01% |
30,000
+10,500
| +54% | +$58K |
|
|
HUYA
2133
Huya Inc
HUYA
$542M
| $187K | ﹤0.01% |
53,000
-4,300
| -8% | -$15.6K |
|
|
API
2134
Agora
API
$326M
| $186K | ﹤0.01% |
48,900
+24,700
| +102% | +$86K |
|
2135
Five Point Holdings
FPH
$379M
| $185K | ﹤0.01% |
33,700
-800
| -2% | -$4.28K |
|
2136
Candel Therapeutics
CADL
$700M
| $185K | ﹤0.01% |
+36,485
| New | +$188K |
|
2137
Prelude Therapeutics
PRLD
$305M
| $182K | ﹤0.01% |
225,000
-35,400
| -14% | -$30.7K |
|
2138
Alto Neuroscience
ANRO
$1.04B
| $181K | ﹤0.01% |
82,200
+67,900
| +475% | +$162K |
|
2139
Myers Industries
MYE
$1.18B
| $180K | ﹤0.01% |
12,455
-22,397
| -64% | -$273K |
|
|
QVCGA
2140
DELISTED
QVC Group Inc Series A
QVCGA
| $180K | ﹤0.01% |
65,522
-42,853
| -40% | -$247K |
|
|
ITOS
2141
DELISTED
iTeos Therapeutics
ITOS
| $179K | ﹤0.01% |
+18,000
| New | +$145K |
|
2142
Cars.com
CARS
$641M
| $178K | ﹤0.01% |
+15,006
| New | +$165K |
|
2143
OraSure Technologies
OSUR
$273M
| $177K | ﹤0.01% |
59,000
-8,100
| -12% | -$23.4K |
|
2144
Radcom
RDCM
$218M
| $177K | ﹤0.01% |
+13,000
| New | +$159K |
|
2145
Sana Biotechnology
SANA
$885M
| $176K | ﹤0.01% |
+64,570
| New | +$133K |
|
2146
Enviri
NVRI
$621M
| $175K | ﹤0.01% |
20,200
+1,800
| +10% | +$13.2K |
|
2147
First Majestic Silver
AG
$8.05B
| $174K | ﹤0.01% |
21,075
-761,880
| -97% | -$5.12M |
|
2148
Ardmore Shipping
ASC
$678M
| $172K | ﹤0.01% |
17,900
-18,100
| -50% | -$174K |
|
|
CTNM
2149
Contineum Therapeutics
CTNM
$526M
| $172K | ﹤0.01% |
+43,200
| New | +$188K |
|
2150
Viant Technology
DSP
$214M
| $171K | ﹤0.01% |
12,900
-3,700
| -22% | -$50.7K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q2 2025 Portfolio in Review
As of Q2 2025, Two Sigma Advisers held 2,611 positions worth $48.8B, up 9.9% from $44.4B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Two Sigma Advisers's Q2 2025 filing shows 251 new, 862 increased, 1,166 reduced and 311 closed positions. Its largest new stake was UnitedHealth: 759,500 shares worth $237M. The largest sale was Broadcom, an estimated $768M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
- Two Sigma Advisers's largest Q2 2025 buy was UnitedHealth: 759,500 shares worth $237M.
- Two Sigma Advisers added most to T-Mobile US in Q2 2025, an estimated $479M increase.
- Two Sigma Advisers's biggest Q2 2025 reduction was Broadcom, cutting an estimated $768M.
- Two Sigma Advisers fully exited Advanced Micro Devices in Q2 2025, selling an estimated $155M.
- Two Sigma Advisers's ten largest holdings make up 19% of its $48.8B portfolio in Q2 2025.
- Two Sigma Advisers opened 251 new positions and closed 311 in Q2 2025.
- Two Sigma Advisers's portfolio value rose 9.9% quarter-over-quarter to $48.8B.
Based on Two Sigma Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.